Pharmaroth Labs Inc (ROTH)

PharmaRoth Labs Inc, formerly Fero Industries, Inc was incorporated in the State of Colorado on December 11, 2000. On May 23, 2010, Fero Industries, Inc., a Colorado corporation, entered that certain Asset Acquisition Agreement with Gvest, Inc., an Ontario, Canada Corporation. The Company acquired certain assets directly related to the manufacturing, sale and distribution of that certain product known as Sucanon, which is an herbal remedy for Type II Diabetes. The Company intends to acquire healthcare related companies, products, and technologies. Fero is focused on the medical device, biotechnology, pharmaceutical, nutraceutical, and healthcare IT industries. Sucanon is approved and is sold as an Over-The-Counter herbal remedy for Type II diabetes in Mexico and as a prescription pharmaceutical in Peru. Sucanon has also undergone clinical trials in China and Brazil. Fero's initial focus is on diabetes. The Company has acquired the intellectual property and other exclusive world-wide rights related to the production, marketing, and distribution of Sucanon also known as Diab II, a treatment for Type II diabetes. Its competitors include fully integrated pharmaceutical companies, nutraceutical, and biotechnology companies, universities and public and private research institutions. The development, manufacture and commercialization of pharmaceutical products are generally subject to extensive regulation by various federal and state governmental entities.